Current liabilities increased 368.3%
Current liabilities changed +368.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +368.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -132.1% from the comparable as-filed period.
Operating cash flow changed -127.3% from the comparable as-filed period.
Operating income changed -126.3% from the comparable as-filed period.
Inventory changed +3407.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Cash & equivalents changed -45.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross margin changed -6363 basis points from the comparable as-filed period.
Net income changed +67.8% from the comparable as-filed period.
Operating margin changed +1625920 basis points from the comparable as-filed period.
Research & development changed +41.1% from the comparable as-filed period.
Capital expenditure changed +160.4% from the comparable as-filed period.
Current assets changed +182.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Shares outstanding changed +41.6% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Total assets changed +284.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +180.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed -163066 basis points from the comparable as-filed period.
Trade receivables changed +7041.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Current ratio changed -39.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Revenue changed +9000.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Inventory / revenue changed -36874 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1138564 basis points from the comparable as-filed period.
R&D / revenue changed -964325 basis points from the comparable as-filed period.
Working capital / assets changed -2211 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +975498 basis points from the comparable as-filed period.
Receivables / revenue changed -3387 basis points from the comparable as-filed period.
Gross profit changed -4584.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.